Author(s): An Y, Zhou Y, Ren G, Tian Q, Lu Y, et al.
Purpose: MGb2, a mouse-derived monoclonal antibody specific to gastric carcinoma, was developed in our laboratory. Nevertheless, the potential role of MGb2-antigen/TRAK1 (MGb2-Ag/TRAK1) in colorectal cancer (CRC) is unclear. The aim of this study was to investigate the relationship between MGb2-Ag/TRAK1 expression and the clinicopathological characteristics of CRC. The potential utility of MGb2-Ag/TRAK1 expression as a prognostic indicator was also evaluated.
Methods: Immunohistochemistry and western blot were used to detect MGb2-Ag/TRAK1 expression in 140 CRC tissues. The relationship between MGb2-Ag/TRAK1 expression and clinicopathological characteristics and postoperative survival time was statistically analyzed.
Results: MGb2-Ag/TRAK1 expression in CRC tissues was significantly higher than in normal tissues and was positively correlated with tumor differentiation (p = 0.006), invasion (p = 0.049), and pathological stage (p = 0.032). There was no significant difference between MGb2-Ag/TRAK1 expression and the age or gender of the patient, lymphatic invasion, or distant metastasis (p = 0.586, 0.308, 0.910, and 0.068, respectively). The survival time of CRC patients with high expression of MGb2-Ag/TRAK1 was shorter than the survival time of patients with low MGb2-Ag/TRAK1 expression. Both univariate and multivariate analyses showed that tumor differentiation and MGb2-Ag/TRAK1 expression were two independent and prognostic factors for CRC (p < 0.001).
Referred From: https://pubmed.ncbi.nlm.nih.gov/21573901/
Author(s): Ghafouri-Fard S,Nekoohesh L, Motevaseli E
Author(s): Ploeg M,Aben KK, Kiemeney LA
Author(s): Cheung G,Sahai A, Billia M, Dasgupta P, Khan MS
Author(s): Biagioli MC, Fernandez DC, Spiess PE, Wilder RB
Author(s): Zhu XL, Ai ZH, Wang J, Xu YL, Teng YC
Author(s): Wang HF, Wang JS
Author(s): Schiffer E,Vlahou A, Petrolekas A, Stravodimos K, Tauber R, et al.
Author(s): Chin L, Hahn WC, Getz G, Meyerson M
Author(s): Horvath S, Dong J
Author(s): Langfelder P, Horvath S
Author(s): Kristensen VN,Lingjærde OC,Russnes HG,Vollan HK,Frigessi A, et al.
Author(s): Stranger BE, Stahl EA, Raj T
Author(s): Gautier L, Cope L, Bolstad BM, Irizarry RA
Author(s): Smyth, GK
Author(s): Song L, Langfelder P, Horvath S
Author(s): Zhang W, Zang Z, Song Y, Yang H, Yin Q
Author(s): Mason MJ, Fan G, Plath K, Zhou Q, Horvath S
Author(s): Zhang B, Horvath S
Author(s): Yip AM, Horvath S
Author(s): Li L, Shiga M, Ching WK, Mamitsuka H
Author(s): Xiao X, Moreno-Moral A, Rotival M, Bottolo L, Petretto E
Author(s): Puniya BL, Kulshreshtha D, Verma SP, Kumar S, Ramachandran S
Author(s): Frantzi M,Makridakis M, Vlahou A
Author(s): Zeng T, Sun SY, Wang Y, Zhu H, Chen L
Author(s): Liu R, Wang X, Aihara K, Chen L
Author(s): He D, Liu ZP, Honda M, Kaneko S, Chen L
Author(s): Lezon-Geyda K,Najfeld V, Johnson EM
Author(s): De Giorgi V, Monaco A, Worchech A, Tornesello M, Izzo F, et al.
Author(s): Gout S,Brambilla E, Boudria A, Drissi R, Lantuejoul S, et al.
Author(s): Belkina AC, Blanton WP, Nikolajczyk BS, Denis GV
Author(s): Wyce A,Degenhardt Y, Bai Y, Le B, Korenchuk S, et al.
Author(s): Chan WK,Bhalla AD, Le Hir H, Nguyen LS, Huang L, et al.
Author(s): Karam R,Carvalho J, Bruno I, Graziadio C, Senz J, et al.
Author(s): Wang J,Peng X, Peng W, Wu FX
Author(s): Ghosh M,Brancato SJ, Agarwal PK, Apolo AB
Author(s): Arum CJ,Anderssen E, Tømmerås K, Lundgren S, Chen D, et al.
Author(s): Oppezzo P,Dighiero G
Author(s): Boulalas I,Zaravinos A, Karyotis I, Delakas D, Spandidos DA
Author(s): Ahmad I, Patel R, Liu Y, Singh LB, Taketo MM, et al.
Author(s): Fernández-Medarde A, Santos E